Clinical Trial Update: Adjunctive Therapy to Antibiotics in the Treatment of S. Aureus Ventilator-Associated Pneumonia With AR-301 [Phase 3]

View source ↗

Summary

Phase 3 trial update for AR-301 as adjunctive therapy to antibiotics in Staphylococcus aureus ventilator-associated pneumonia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infection Bacterial
• Lung Infection
• Pneumonia Ventilator-associated
• Staphylococcus Aureus

Drugs mentioned

• AR-301

Snippet

Sponsor: Aridis Pharmaceuticals, Inc. | Conditions: Lung Infection, Pneumonia, Ventilator-Associated | Phase 3 | Status: COMPLETED